Literature DB >> 8743556

Emerging multipotent aspects of hepatocyte growth factor.

K Matsumoto1, T Nakamura.   

Abstract

Specific tissue interactions between epithelia and mesenchyme (or stroma), e.g., epithelial-mesenchymal (or -stromal) interactions mediate crucial aspects of normal development and tissue regeneration. These events affect tissue induction, organogenesis, cell movement, and morphogenesis of multicellular structures. Extensive and diverse studies have established that hepatocyte growth factor (HGF), a ligand for the c-met protooncogene product of receptor tyrosine kinase, is a mesenchymal- or stromal-derived multipotent polypeptide which mediates epithelial-mesenchymal interactions. During embryogenesis, HGF supports organogenesis and morphogenesis of various tissues and organs, including the liver, kidney, lung, gut, mammary gland, tooth, skeletal system, etc. In adult tissues, HGF elicits a potent organotrophic function which supports regeneration of organs including the liver, kidney, and lung. In the brain, HGF is a new member of the family of neurotrophic factors. In neoplastic tissue, HGF is involved in tumor invasion and metastasis, through tumor-stromal interactions. While HGF was originally identified as a potent mitogen for mature hepatocytes, the biological functions of this factor reach far beyond the original identifications. Such being the case, use of HGF for purposes of therapeutics is being given increasing attention.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743556     DOI: 10.1093/oxfordjournals.jbchem.a021283

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  128 in total

Review 1.  Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis.

Authors:  J V Soriano; M S Pepper; L Orci; R Montesano
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

Authors:  D Tulasne; R Paumelle; K M Weidner; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

3.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

Authors:  S Yi; M S Tsao
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

4.  Chromosomal localization of rat hepatocyte growth factor (Hgf) and HGF receptor (Met) and characterization of HGF receptor cDNA.

Authors:  V R Wallenius; H Rawet; S Skrtic; K Helou; Y Qiu; G Levan; S Ekberg; B Carlsson; O G Isaksson; T Nakamura; J O Jansson
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

5.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

6.  Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia.

Authors:  M R Kibbe; A T Hirsch; F O Mendelsohn; M G Davies; H Pham; J Saucedo; W Marston; W-B Pyun; S-K Min; B G Peterson; A Comerota; D Choi; J Ballard; R A Bartow; D W Losordo; W Sherman; V Driver; E C Perin
Journal:  Gene Ther       Date:  2015-12-08       Impact factor: 5.250

7.  NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.

Authors:  Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke Ichikawa; Kazuma Okamoto; Hitoshi Fujiwara; Hisashi Ikoma; Masayoshi Nakanishi; Shojiro Kikuchi; Chouhei Sakakura; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Kunio Matsumoto; Toshikazu Nakamura; Eigo Otsuji
Journal:  Clin Exp Metastasis       Date:  2009-02-21       Impact factor: 5.150

8.  Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Authors:  Kyung Hee Lee; Eun Young Choi; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Heon Ju Lee; Jong Yuel Eun; Hong Gin Kim; Sung Soo Yoon; Dong Sik Lee; Jung Hye Kim; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2007-11-09       Impact factor: 5.150

9.  Hepatocyte growth factor-induced Asef-IQGAP1 complex controls cytoskeletal remodeling and endothelial barrier.

Authors:  Yufeng Tian; Grzegorz Gawlak; Alok S Shah; Katherine Higginbotham; Xinyong Tian; Yoshihiro Kawasaki; Tetsu Akiyama; David B Sacks; Anna A Birukova
Journal:  J Biol Chem       Date:  2014-12-09       Impact factor: 5.157

10.  Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.

Authors:  Anna A Birukova; Ivan Cokic; Nurgul Moldobaeva; Konstantin G Birukov
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-29       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.